The long-term goal of this project is to elucidate the functional roles of glycosphingolipids (GSLs), particularly gangliosides, during normal nervous system development and under pathological conditions. These molecules are abundant in the nervous system and are primarily localized on the plasma membrane surface. Dramatic, consistent changes in ganglioside expression are observed during neurogenesis and maturation, particularly during the early stages of brain development. The primary localization of gangliosides on cell surface microdomains and the drastic quantitative and compositional changes during brain development strongly suggest that these GSLs are involved in modulating the fate regulation of neural stem cells (NSCs) and neural precursor cells (NPCs). A large body of knowledge has been firmly established regarding the expression of stage-specific GSL antigens on these cells and their role in neuronal migration and signal regulation. In this investigation, we will perform biochemical, cell biological, and molecular biological analyses to investigate the expression patterns of gangliosides, the involvement of gangliosides in neural cell fate determination, and the regulatory mechanisms of glycosyltransferases (GTs). We will focus on NSCs/NPCs because these cells have already committed to neural cell lineage differentiation and are capable of further differentiating into various cell types in response to such developmental cues as cytokines and growth factors. Our studies will be focused on the following two specific aims: (1) Elucidation of the functions of gangliosides in regulation of NSC/NPC cell fate determination, such as self-renewal, proliferation, differentiation, migration, and survival, (2) Characterization of the post-translational regulatory mechanisms of GTs responsible for the dramatic changes of ganglioside expression during NPC differentiation. At present, very few systematic studies have been done in the glycobiology of NSCs/NPCs. The research proposed here is intended to fill this gap. An understanding of the molecular mechanisms underlying the differential expression of cell surface gangliosides should greatly enhance our knowledge of their function in normal brain development and in developmental disorders that result in mental retardation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS011853-34A2
Application #
7680665
Study Section
Special Emphasis Panel (ZRG1-MDCN-D (03))
Program Officer
Owens, David F
Project Start
1988-07-01
Project End
2011-06-30
Budget Start
2009-07-16
Budget End
2010-06-30
Support Year
34
Fiscal Year
2009
Total Cost
$361,250
Indirect Cost
Name
Georgia Regents University
Department
Neurology
Type
Schools of Medicine
DUNS #
966668691
City
Augusta
State
GA
Country
United States
Zip Code
30912
Itokazu, Yutaka; Wang, Jing; Yu, Robert K (2018) Gangliosides in Nerve Cell Specification. Prog Mol Biol Transl Sci 156:241-263
Itokazu, Yutaka; Tsai, Yi-Tzang; Yu, Robert K (2017) Epigenetic regulation of ganglioside expression in neural stem cells and neuronal cells. Glycoconj J 34:749-756
Tsai, Yi-Tzang; Itokazu, Yutaka; Yu, Robert K (2016) GM1 Ganglioside is Involved in Epigenetic Activation Loci of Neuronal Cells. Neurochem Res 41:107-15
Yu, Robert K; Usuki, Seigo; Itokazu, Yutaka et al. (2016) Novel GM1 ganglioside-like peptide mimics prevent the association of cholera toxin to human intestinal epithelial cells in vitro. Glycobiology 26:63-73
Koon, Noah A; Itokazu, Yutaka; Yu, Robert K (2015) Ganglioside-Dependent Neural Stem Cell Proliferation in Alzheimer's Disease Model Mice. ASN Neuro 7:
Itokazu, Yutaka; Yu, Robert K (2014) Amyloid ?-peptide 1-42 modulates the proliferation of mouse neural stem cells: upregulation of fucosyltransferase IX and notch signaling. Mol Neurobiol 50:186-96
Usuki, Seigo; O'Brien, Dawn; Rivner, Michael H et al. (2014) A new approach to ELISA-based anti-glycolipid antibody evaluation of highly adhesive serum samples. J Immunol Methods 408:52-63
Parameswaran, Reshmi; Lim, Min; Arutyunyan, Anna et al. (2013) O-acetylated N-acetylneuraminic acid as a novel target for therapy in human pre-B acute lymphoblastic leukemia. J Exp Med 210:805-19
Wang, Jing; Yu, Robert K (2013) Interaction of ganglioside GD3 with an EGF receptor sustains the self-renewal ability of mouse neural stem cells in vitro. Proc Natl Acad Sci U S A 110:19137-42
Ariga, Toshio; Itokazu, Yutaka; McDonald, Michael P et al. (2013) Brain gangliosides of a transgenic mouse model of Alzheimer's disease with deficiency in GD3-synthase: expression of elevated levels of a cholinergic-specific ganglioside, GT1a?. ASN Neuro 5:141-8

Showing the most recent 10 out of 199 publications